Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NAFLD (Non-alcoholic Fatty Liver Disease)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT00247117
What this trial is testing

Metformin in Patients With Non-Alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Liver Diseases
Kaplan Medical Center 15
Large-scale testing (Phase 3)Looking for participantsNCT07221227
What this trial is testing

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

Who this might be right for
Non-alcoholic Fatty Liver Disease
GlaxoSmithKline 1,200
Not applicableUnknownNCT02488941
What this trial is testing

Mapping of Metabolic Liver Functions in Patients With Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver Disease
University of Aarhus 30
Not applicableEnrolling By InvitationNCT03308773
What this trial is testing

Disease Prevention in Clinical Practice Base on Patient Specific Physiology

Who this might be right for
PreDiabetesInsulin ResistanceType2 Diabetes+7 more
Pacific Coast Family Medical Group 5,000
Testing effectiveness (Phase 2)Study completedNCT04771273
What this trial is testing

Test Safety and Efficacy of Survodutide (BI456906) in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3)

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
Boehringer Ingelheim 295
Not applicableStudy completedNCT04999124
What this trial is testing

Characteristics of NAFLD Among Type 2 Diabetes Patients

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseType2 Diabetes
Ziekenhuis Oost-Limburg 1,762
Not applicableLooking for participantsNCT07068191
What this trial is testing

Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)HepatomegalyNonalcoholic Fatty Liver (NAFL)+5 more
Phenomen Pharma 90
Not applicableStudy completedNCT02337660
What this trial is testing

Involvement of Steatosis-induced Glucagon Resistance in Hyperglucagonaemia

Who this might be right for
Non-alcoholic Fatty Liver Disease
University Hospital, Gentofte, Copenhagen 30
Testing effectiveness (Phase 2)Ended earlyNCT01672879
What this trial is testing

Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH

Who this might be right for
Liver Fibrosis Due to NASH
Gilead Sciences 259
Not applicableLooking for participantsNCT03635541
What this trial is testing

Dynamic Changes and Risk Factors of Fibrosis and Steatosis Progression in Nonalcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Beijing Friendship Hospital 500
Not applicableStudy completedNCT00714129
What this trial is testing

De Novo Lipogenesis, Lipid and Carbohydrate Metabolism in Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver DiseaseDiabetes
University of California, San Francisco 41
Not applicableUnknownNCT04669470
What this trial is testing

Bariatric Endoscopy and NAFLD

Who this might be right for
ObesityNAFLDLiver Steatosis+1 more
University of Ostrava 100
Post-approval studies (Phase 4)Study completedNCT05898841
What this trial is testing

Study to Evaluate the Efficacy and Safety of a Rilpivarine-based Antiretroviral Tratment Regimen in HIV- Infected Patients With Liver Metabolic Disease Who Maintain Udetectable HIV Viral Load

Who this might be right for
HIV InfectionsFatty Liver Disease
Fundacion SEIMC-GESIDA 63
Very early researchStudy completedNCT05720702
What this trial is testing

A Feasibility Trial of OCM Supplements for the Treatment of NAFLD

Who this might be right for
NAFLD
Duke University 31
Testing effectiveness (Phase 2)Looking for participantsNCT06133101
What this trial is testing

Impact of Soymilk on Liver Disease Severity of Children With Non-alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Marialena Mouzaki 44
Not applicableStudy completedNCT03339245
What this trial is testing

Effects of Dietary Fructose on Gut Microbiota and Fecal Metabolites in Obese Men and Postmenopausal Women: A Pilot Study

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseObesity
Rockefeller University 13
Not applicableEnrolling By InvitationNCT06942312
What this trial is testing

Elucidating Hepatic Metabolism in Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)
Helsinki University Central Hospital 30
Testing effectiveness (Phase 2)Study completedNCT04505436
What this trial is testing

Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) in Subjects

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Hanmi Pharmaceutical Company Limited 215
Testing effectiveness (Phase 2)Ended earlyNCT03198572
What this trial is testing

Efficacy and Safety of Berberine in Non-alcoholic Steatohepatitis

Who this might be right for
Non-alcoholic Steatohepatitis
Fudan University 89
Not applicableStudy completedNCT05669677
What this trial is testing

Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease

Who this might be right for
Chronic or Recovered Hepatitis BChronic or Recovered Hepatitis CChronic or Recovered Hepatitis D+2 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 233
Next Page